UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Compensatory Arrangements of Certain Executive Officers
On January 24, 2025, the Compensation Committee (the “Compensation Committee”) of the Board of Directors of Sight Sciences, Inc. (the “Company”) approved annual base salaries and target cash incentive bonus opportunities for the fiscal year ending December 31, 2025 (“Fiscal 2025”) for certain of the Company’s executive officers, including Paul Badawi, the Company’s President and Chief Executive Officer, Alison Bauerlein, the Company’s Chief Financial Officer and Treasurer, and Matthew Link, the Company’s Chief Commercial Officer.
Fiscal 2025 Base Salary
The annual base salary amounts received for the fiscal year ended December 31, 2024 (“Fiscal 2024”) and to be received for Fiscal 2025 by Mr. Badawi, Ms. Bauerlein, and Mr. Link are set forth opposite their names in the table below:
Name |
Annual Base Salary (Fiscal 2024) |
Annual Base Salary (Fiscal 2025) |
Paul Badawi |
$640,000 |
$659,000 |
Alison Bauerlein |
$450,000 |
$473,000 |
Matthew Link |
$420,000 |
$433,000 |
Fiscal 2025 Cash Incentive Program
The Company maintains an annual cash incentive program for all employees who are not eligible for commissions and who are otherwise eligible to participate in the program, including Mr. Badawi, Ms. Bauerlein, and Mr. Link.
The target bonus opportunity is set as a percentage of the participant’s base salary for the year as determined by the Compensation Committee. The Compensation Committee approved the following Fiscal 2025 target bonus opportunities for Mr. Badawi, Ms. Bauerlein, and Mr. Link, as set forth opposite their respective names in the table below:
Name |
Target Bonus Opportunity Percentage |
Paul Badawi |
75% |
Alison Bauerlein |
60% |
Matthew Link |
50% |
The Fiscal 2025 cash incentive program applicable to executive officers will be earned based exclusively on achievement by the Company of specified predetermined milestones relating to revenue, adjusted operating expense, key market access milestones, key clinical and R&D milestones, and key commercial launch milestones.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Sight Sciences, Inc. |
|
|
|
|
Date: |
January 28, 2025 |
By: |
/s/ Alison Bauerlein |
|
|
|
Chief Financial Officer |